Showing 1 to 1 of 1 results
theguardian.com
🌐 85% Global Worthiness
Eli Lilly CEO Calls UK "Worst in Europe" for Drug Prices, Threatening Investment
Eli Lilly's CEO, Dave Ricks, criticized the UK's drug pricing regime as the "worst in Europe," citing it as a reason for the pharmaceutical industry's withdrawal of nearly £2 billion in planned investments.
Eli Lilly CEO Calls UK "Worst in Europe" for Drug Prices, Threatening Investment
Eli Lilly's CEO, Dave Ricks, criticized the UK's drug pricing regime as the "worst in Europe," citing it as a reason for the pharmaceutical industry's withdrawal of nearly £2 billion in planned investments.
Progress
56% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results